期刊文献+

尿毒清颗粒治疗慢性肾功能衰竭临床疗效观察 被引量:14

暂未订购
导出
摘要 目的探讨口服尿毒清颗粒配合西药治疗早中期慢性肾功能衰竭患者的疗效。方法治疗组41例慢性肾功能衰竭患者予口服尿毒清颗粒配合基础治疗,并设对照组20例仅予基础治疗。结果治疗组症状改善率、血肌酐及尿素氮下降幅度明显高于对照组。结论尿毒清颗粒对早中期慢性肾功能衰竭患者有明显疗效。
出处 《现代中西医结合杂志》 CAS 2009年第23期2794-2795,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献4

二级参考文献12

  • 1杨俊伟,黎磊石.大黄延缓慢性肾衰进展的实验研究[J].中华肾脏病杂志,1993,9(2):65-68. 被引量:205
  • 2Yang JW,Liu YH.Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.Am J Pathol,2001,159:1465-1475.
  • 3Eddy AA.Molecular basis of renal fibrosis.Pediatr Nephrol,2000,15:290-301.
  • 4Kalluri R,Neilson EC.Epithelial-mesenchymal transition and its implications for fibrosis.J Clin Invest,2003,112:1776-1784.
  • 5Liu YH.Epithelial to mesenchymal transition in renal fibrogenesis:pathologic significance,molecular mechanism and therapeutic intervention.J Am Soc Nephrol,2004,15:1-12.
  • 6Yang JW,Shultz RW,Mars WM,et al.Disruption of tissuetype plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.J Clin Invest,2002,110:1525-1538.
  • 7Yang JW,Liu YH.Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis.J Am Soc Nephrol,2002,13:96-107.
  • 8Massague J.How cells read TGF-beta signals.Nat Rev Mol Cell Biol,2000,1:169-178.
  • 9Border WA,Noble NA.TGF-beta in kidney fibrosis:a target for gene therapy.Kidney Int,1997,51:1388-1396.
  • 10Yang JW,Dai CS,Liu YH.A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.J Am Soc Nephrol,2005,16:68-78.

共引文献318

同被引文献127

引证文献14

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部